Page 86 - TD-4-1

Tumor Discovery Colorectal cancer: miRNA, mRNA, protein insights

confirming recent cDNA expression analyses. Int J Cancer. prognosis in patients with colorectal cancer. Int J Colorectal
2005;116(3):340-350. Dis. 2013;28(1):19-24.
doi: 10.1002/ijc.21004 doi: 10.1007/s00384-012-1528-1
26. Pandey S, Jain A, Vagha S. Insights into colorectal carcinoma: 33. Liu C, Yu C, Song G, et al. Comprehensive analysis of
A comprehensive review of MicroRNA expression patterns. miRNA-mRNA regulatory pairs associated with colorectal
Cureus. 2024;16(3):e56739. cancer and the role in tumor immunity. BMC Genomics.
doi: 10.7759/cureus.56739 2023;24(1):724
27. Muhammad S, Kaur K, Huang R, et al. MicroRNAs in doi: 10.1186/s12864-023-09635-4
colorectal cancer: Role in metastasis and clinical perspectives. 34. Prakash S, Alisha G. MicroRNAs: Potential biomarkers for
World J Gastroenterol. 2014;20(45):17011-17019. diagnosis and prognosis of different cancers. Transl Cancer
doi: 10.3748/wjg.v20.i45.17011 Res. 2020;9(9):5798-5818.
28. Al-Nakhle HH. Unraveling the multifaceted role of doi: 10.21037/tcr-20-1294
the miR-17-92 cluster in colorectal cancer: From 35. Ramesh P, Medema JP. BCL-2 family deregulation in
mechanisms to biomarker potential. Curr Issues Mol Biol. colorectal cancer: Potential for BH3 mimetics in therapy.
2024;46(3):1832-1850. Apoptosis. 2020;25(5-6):305-320.
doi: 10.3390/cimb46030120 doi: 10.1007/s10495-020-01601-9
29. Santos DAR, Gaiteiro C, Santos M, Santos L, Dinis-Ribeiro M, 36. Yu T, Ma P, Wu D, Shu Y, Gao W. Functions and mechanisms
Lima L. MicroRNA biomarkers as promising tools for early of microRNA-31 in human cancers. Biomed Pharmacother.
colorectal cancer screening-a comprehensive review. Int J 2018;108:1162-1169.
Mol Sci. 2023;24(13):11023.
doi: 10.1016/j.biopha.2018.09.132
doi: 10.3390/ijms241311023
37. Ahadi A. The significance of microRNA deregulation in
30. Fellizar A, Refuerzo V, Ramos JD, Albano PM. Expression colorectal cancer development and the clinical uses as a
of specific microRNAs in tissue and plasma in colorectal diagnostic and prognostic biomarker and therapeutic agent.
cancer. J Pathol Transl Med. 2023;57(3):147-157. Noncoding RNA Res. 2020;5(3):125-134.
doi: 10.4132/jptm.2022.02.19 doi: 10.1016/j.ncrna.2020.08.003
31. Schepeler T, Reinert JT, Ostenfeld MS, et al. Diagnostic and 38. Sasso CV, Lhamyani S, Hevilla F, et al. Modulation of miR-
prognostic microRNAs in stage II colon cancer. Cancer Res. 29a and miR-29b Expression and their target genes related
2008;68(15):6416-6424.
to inflammation and renal fibrosis by an oral nutritional
doi: 10.1158/0008-5472.CAN-07-6110 supplement with probiotics in malnourished hemodialysis
patients. Int J Mol Sci. 2024;25:1132.
32. Zhou T, Zhang G, Liu Z, Xia S, Tian H. Overexpression
of miR-92a correlates with tumor metastasis and poor doi: 10.3390/ijms25021132

Volume 4 Issue 1 (2025) 78 doi: 10.36922/td.4631